-
-
-
-
-
-
-
Corcept presents survival data for Lifyorli in ovarian cancer at ASCO
-
-
-
-
-
-
-
Wolfe Research Upgrades Corcept Therapeutics (CORT) to Peerperform
-
-
-
-
-
-
-
Corcept Therapeutics stock falls after losing key patent case appeal
-
-
-
-
-
-
-
Corcept Therapeutics (CORT) call put ratio 1 call to 2.4 puts as share price down 51%
-
-
-
-
-
-
-
Wolfe Research Starts Corcept Therapeutics (CORT) at Peerperform
-
-
-
-
-
-
-
Corcept Therapeutics (CORT) Tops Q2 EPS by 10c ; Offers Guidance
-
-
-
-
-
-
-
Corcept Therapeutics (CORT) Presents Pivotal Clinical Data in ASCO Late-Breaker with Simultaneous Publication in The Lancet
-
438,514 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

